Table 1.
Parameter | Group | EAC | SD1 | SD5 | SC1 | SC5 |
---|---|---|---|---|---|---|
XOD | Pretreatment | 0.156 ± 0.009 | 0.142 ± 0.004 b | 0.151 ± 0.005 b | 0.807 ± 0.138 a,* | 0.822 ± 0.057 *,a |
Treatment | 0.104 ± 0.011 c,* | 0.836 ± 0.069 b,* | 1.035 ± 0.064 a,* | 1.012 ± 0.014 a,* | ||
Posttreatment | 0.220 ± 0.014 a,* | 0.102 ± 0.005 b,* | 0.097 ± 0.012 b,* | 0.101 ± 0.004 b,* | ||
CAT | Pretreatment | 0.503 ± 0.013 | 0.585 ± 0.019 a,* | 0.429 ± 0.002 b,* | 0.233 ± 0.016 c,* | 0.136 ± 0.002 d* |
Treatment | 0.636 ± 0.027 a,* | 0.138 ± 0.002 c,* | 0.194 ± 0.006 b,* | 0.191 ± 0.003 b,* | ||
Post-treatment | 0.316 ± 0.008 b,* | 0.698 ± 0.052 a,* | 0.713 ± 0.002 a,* | 0.742 ± 0.041 a,* | ||
Px | Pretreatment | 0.325 ± 0.023 | 0.302 ± 0.016 c | 0.432 ± 0.010 c,* | 0.618 ± 0.003 b,* | 0.881 ± 0.019 a,* |
Treatment | 0.120 ± 0.006 c,* | 0.875 ± 0.035 a,* | 0.715 ± 0.004 b,* | 0.710 ± 0.002 b,* | ||
Post-treatment | 0.474 ± 0.035 a,* | 0.100 ± 0.008 b,* | 0.114 ± 0.023 b,* | 0.118 ± 0.007 b,* | ||
GR | Pretreatment | 2.187 ± 0.107 | 2.115 ± 0.165 b | 3.012 ± 0.105 b,* | 4.957 ± 0.135 a,* | 5.707 ± 0.667 a,* |
Treatment | 1.202 ± 0.095 b,* | 5.627 ± 0.363 a,* | 5.172 ± 0.111 a,* | 5.195 ± 0.024 a,* | ||
Post-treatment | 3.930 ± 0.217 a,* | 1.195 ± 0.002 b,* | 1.254 ± 0.028 b,* | 1.284 ± 0.185 b,* | ||
GSHPx | Pretreatment | 0.779 ± 0.048 | 0.796 ± 0.024 d | 0.933 ± 0.022 c,* | 1.302 ± 0.049 b,* | 1.697 ± 0.038 a,* |
Treatment | 0.474 ± 0.034 b,* | 1.91 ± 0.345 a,* | 2.043 ± 0.020 a,* | 2.007 ± 0.031 a,* | ||
Post-treatment | 1.131 ± 0.151 a,* | 0.395 ± 0.065 b,* | 0.401 ± 0.068 b,* | 0.421 ± 0.005 b,* | ||
GSH | Pretreatment | 1.603 ± 0.110 | 1.417 ± 0.056 a,* | 1.358 ± 0.029 a,* | 0.871 ± 0.033 b,* | 0.884 ± 0.043 b,* |
Treatment | 1.513 ± 0.058 a,* | 0.926 ± 0.069 b,* | 0.621 ± 0.011 c,* | 0.635 ± 0.005 c,* | ||
Post-treatment | 1.105 ± 0.063 b,* | 1.801 ± 0.045 a,* | 1.799 ± 0.029 a,* | 1.842 ± 0.003 a,* | ||
LPx | Pretreatment | 0.032 ± 0.008 | 0.030 ± 0.009 c | 0.041 ± 0.003 c | 0.100 ± 0.007 a,* | 0.080 ± 0.005 b,* |
Treatment | 0.022 ± 0.005 c | 0.042 ± 0.521 b | 0.077 ± 0.005 a | 0.083 ± 0.005 a | ||
Post-treatment | 0.056 ± 0.018 a,* | 0.011 ± 0.006 b,* | 0.019 ± 0.006 b,* | 0.014 ± 0.001 b,* |
Results are presented as a mean value ± SD from six mice. *—statistically significant difference compared to the EAC control group; different letters within a row indicate a significant difference between the samples in the same group at p < 0.05.